Sunstein Life Sciences - Team

Brings prosecution skills to bear in defending companies' rights in innovation and discovery. Prosecution involves IV delivery systems, blood processing equipment, surgical instruments, diagnostic equipment, and pharmaceuticals. Experience with patent litigation and interferences relating to pharmaceuticals and medical devices.

Nancy C. Wilker, Ph.D

Uses her experience with patents, trademarks, trade secrets, product clearance, due diligence, and intellectual property agreements to help her clients maximize value and avoid problems.  Prepares and prosecutes patents in a variety of biotech areas including transgenic plants and animals, cancer biomarkers, stem cells, new genes, vaccines, antibodies, biological and small molecule chemical therapeutics, nucleic acid and protein detection and analysis technologies.  Manages global patent and trademark portfolios. 

Isabelle Blundell, Ph.D.

With her 15 years of experience practicing patent law, handles patent prosecution matters, portfolio development, product clearance, intellectual property due diligence, and agreements involving transfer of intellectual property in the chemical and life sciences fields. Prepares and prosecutes patents in the fields of chemistry, pharmaceuticals, biochemistry, diagnostics, and medical devices, including patents for small molecules for immune-mediated diseases, solid organ transplant, neglected diseases, pharmaceutical additives for drug delivery, and synthetic polymers and biomaterials for tissue healing, cosmetic and orthopedic applications. Utilizes her experience in law firm and corporate settings for effectively working with inventors.

Combines expertise in patent protection with formulating sound business strategy. Has prosecuted in the fields of neuromedical measurement devices, surgical instruments, ultrasonic bone densitometers, infusion pumps, gene expression assays and indices, and polysaccharide-based compositions and methods.

Leads patent prosecution and enforcement, including reexaminations and litigation in areas such as medical equipment, surgical methods, and pharmaceuticals.

Concentrates in patent preparation and prosecution and brings 8 years of industry experience as an engineer in the medical device, pharmaceutical, and industrial radiography fields. Prosecutes patents for medical and dental devices including medical valves, medical imaging and analysis equipment, laboratory and research equipment, surgical equipment and instruments, and blood processing equipment. In the biotech industry, worked on development of ultrasound imaging agents and reformulation of cancer drugs.

Prosecutes patents and counsels clients on strategic issues relating to their portfolios involving a wide array of technologies including pharmaceuticals, medical devices, diagnostic equipment, chemical processes, and nanotechnology.

Life Science Litigation, Trademark and Business Practice Leaders

Patent litigation leader with experience in strategic direction of life sciences litigation matters, including in areas such as pharmaceuticals, dialysis machines, electrochemical medical diagnostic devices, surgical methods, and intravenous valves and equipment.

Patent, trademark and copyright litigator with extensive experience in the development, management and enforcement of the trademark portfolios of local and global biotechnology and pharmaceutical companies. Lisa writes and lectures on the topic of pharmaceutical trademarks, including regarding the interplay of USPTO and FDA procedures, and is a member of the UK-based Pharmaceutical Trademarks Group (PTMG).

Tom has negotiated license agreements for large pharmaceutical companies, engineered the licensing, purchase and sale of patents for large and small companies (including on an anonymous basis), counseled overseas investors on tax-efficient structures for establishing research and development facilities in the US, and counseled inventors seeking to commercialize their life sciences discoveries. He has written several articles about patent litigation involving generic challenges to pharmaceutical patents.

^ Return to top